Account

Sign in to access your account and subscription

Test Case Linking Vaccines and Autism Reaches Federal Court

'Words alone cannot explain the trauma of watching your only child's health deteriorate to such a degree before your eyes,' Theresa Cedillo of Arizona wrotes in an e-mail to Legal Times, a sister publication of this newsletter. On June 11, the case of Michelle Cedillo, Theresa's daughter, will go before an extraordinary tribunal assembled by the U.S. Court of Federal Claims. Its goal is to determine, for the first time in a judicial proceeding, whether the combination of certain vaccines and thimerosal, a mercury-based vaccine preservative, can cause autism ' a set of disorders that is gaining attention as more and more children are diagnosed; as many as one in 150 children born in the United States. The government has long denied such a link exists.

20 minute read June 28, 2007 at 02:08 PM
By
Tony Mauro
Test Case Linking Vaccines and Autism Reaches Federal Court

The family stories are remarkably, painfully, similar. They begin with toddlers developing well, and happily. Then they are taken to the doctor's office for routine vaccines, which in the early 1990s often were bundled together.

This premium content is locked for LawJournalNewsletters subscribers only

ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN LawJournalNewsletters

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

Already have an account? Sign In Now

For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.

NOT FOR REPRINT

© 2026 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Continue Reading

The combination of increasing operating costs and uncertain government reimbursement funding continues to place health care providers under financial pressure, and in many cases, financial distress. Given the importance of Medicare/Medicaid funding of claims under provider agreements with the federal government, how courts interpret and apply the interplay between the Bankruptcy Code and Medicare Program Act determines the disposition of hundreds of millions of dollars of claims for reimbursement that support the health care system.

April 30, 2026

As AI becomes embedded in everyday business and legal operations, organizations are confronting a new expectation: simply disclosing AI use is no longer enough. A critical shift is taking place in the legal industry: transparency is no longer just about disclosure; it’s about comprehension.

April 30, 2026